Global Innovative Platforms GIPL
OTC GIPL
$0.50 +0.00 (+0.00%)
At close: Oct 19, 2026 · 4:00 PM EDT

Global Innovative Platforms (GIPL) Cash from Financing Activities (2020 - 2026)

Updated

Global Innovative Platforms (GIPL) reported Cash from Financing Activities of $105,646 for fiscal Q3 2026 (quarter ended Jun 30, 2026), down 53.4% from $226,501 a year earlier and down 78.7% from the prior quarter.

Analysis

Global Innovative Platforms (GIPL) Cash from Financing Activities (2020 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Global Innovative Platforms' Cash from Financing Activities came in at $680,000, down 8.6% year-over-year; for FY2025 (ended Sep 30, 2025), it came in at $754,001, up 766.9% from FY2024.

  • Cash from Financing Activities has a five-year compound annual growth rate of 265.0% (FY2020 to FY2025).
  • By fiscal year, Cash from Financing Activities came in at $86,978 in FY2024 (-53.6%), $187,451 in FY2023 (+85.4%) and $101,115 in FY2022.
  • Five-year quarterly Cash from Financing Activities spans a low of -$18,500 in fiscal Q4 2021 and a high of $495,854 in fiscal Q2 2026.
  • Year over year, Cash from Financing Activities gained in two of the last five quarters, with growth averaging 2.6%.
  • The high point for year-over-year Cash from Financing Activities in five years was fiscal Q2 2024 (growth of 920.4%); the low point was fiscal Q1 2026 (a decline of 93.5%).
  • Per Business Quant data, the three fiscal quarters before Q3 2026 came in at $495,854 (Q2 2026), $18,500 (Q1 2026) and $60,000 (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 8.43 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn -8.78 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn -5.05 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 1.76 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn -2.02 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn -3.89 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn -1.48 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 2.34 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn -3.66 Bn
10 Global Innovative Platforms 24.88 Mn 24.27 Mn - 105,646.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 105,646.00
Mar 31, 2026 -634,855.00
Dec 31, 2025 1.15 Mn
Sep 30, 2025 436,708.00
Jun 30, 2025 226,501.00
Mar 31, 2025 -195,709.00
Dec 31, 2024 663,209.00
Sep 30, 2024 339,312.00
Jun 30, 2024 9,990.00
Mar 31, 2024 1,500.00
Dec 31, 2023 25,906.00
Sep 30, 2023 178,677.00
Jun 30, 2023 11,053.00
Mar 31, 2023 147.00
Dec 31, 2022 99,853.00
Sep 30, 2022 90,779.00
Jun 30, 2022 11,500.00
Sep 30, 2021 -18,500.00
Jun 30, 2021 -31,340.00
Mar 31, 2021 39,951.00
API Access

Global Innovative Platforms Cash from Financing Activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=GIPL&period=max&api_key=YOUR_API_KEY